15 /100
LOW RISK
Score updated Jul 13, 2026

CLBT — Cellebrite DI Ltd. Dilution Risk Tracker

Track CLBT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CLBT — Get alerts when the score changes →

As of July 13, 2026, Cellebrite DI Ltd. (CLBT) has a DilutionWatch DilutionScore of 15/100, rated LOW dilution risk. Cellebrite DI Ltd. has a market capitalization of $3.67B, 249.44M shares outstanding, 225 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
22
💰 Cash Runway
0
📊 Float Risk
32
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for CLBT.
🔔 Track CLBT — Get forecast alerts →

💹 Market Data

Market Cap$3.67B
Shares Outstanding249.44M
Float122.01M
Cash$276.00M
Debt$22.80M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 0.2% shares (2026Q1 vs prior)
225 institutional holders · 135.24M shares
#1 True Wind Capital Management, L.P. 13.86M shares
#2 Voss Capital, LP 9.88M shares
#3 FMR LLC 8.49M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest6.95M
Days to Cover3.1
% of Float5.7%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2021
Full SEC filing analysis available with free account →

📰 Recent News

No recent news

📋 What This Means for CLBT Shareholders

Cellebrite DI Ltd. (CLBT) has a DilutionScore of 15/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for CLBT shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for CLBT in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for CLBT alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track CLBT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CLBT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

LBTYA LBTYK AER AIG BABA

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for CLBT
📊 CLBT FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CLBT Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.